Drug Markets/Entecavir Anhydrous

Entecavir Anhydrous

2 NDCs across 1 manufacturer|2 Generic,0 Brand

Entecavir Anhydrous is used to treat chronic hepatitis b, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Entecavir Anhydrous is available as 2 NDCs from 1 manufacturer (2 generic, 0 brand), with NADAC prices from $0.22 to $0.37 per EA — a 69% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

2G / 0B

Manufacturers

1

competing in market

Price Spread

$0.22 – $0.37

per EA

7d Activity

2↑0 flat

avg +1.6% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ENTECAVIR ANHYDROUS

Drug Portfolio

2 NDCs total, 2 shown

Frequently Asked Questions

What is Entecavir Anhydrous used to treat?

Entecavir Anhydrous is used to treat chronic hepatitis b, per the National Library of Medicine's MED-RT classification.

How many Entecavir Anhydrous products are on the market?

The Entecavir Anhydrous drug market contains 2 NDCs from 1 manufacturer — 2 generic and 0 brand products.

What is the price range for Entecavir Anhydrous?

NADAC reference prices for Entecavir Anhydrous range from $0.2186 to $0.3684 per EA — a 69% difference between cheapest and most expensive.

Which manufacturers make Entecavir Anhydrous?

1 manufacturer lists Entecavir Anhydrous in NADAC. Ranked by number of NDCs, the largest are Cameron Pharmaceuticals (2).

How has the price of Entecavir Anhydrous changed recently?

Over the past 7 days, 2 Entecavir Anhydrous NDCs rose and 0 fell, with a market-wide average change of +1.6%.